Antiarrhythmic (s)-enantiomers of methanesulfonamides

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 311/08 (2006.01) A61K 31/18 (2006.01)

Patent

CA 2207545

(S)-Enantiomeric methanesulfonamides are structurally depicted by formula (I) or its pharmacologically acceptable salts where R3 is a C1-9 alkyl substituted with one fluorine atom. These compounds are useful as Class III antiarrhythmic agents without the undesirable side effect of polymorphic ventricular tachycardia (PVT) and are stable against rapid metabolism. Use of the compounds of formula (I) in the preparation of compositions for treating cardiac arrhythmias are also described.

Méthane-sulfonamides énantiomères (S) décrits, au point de vue de la structure, par la formule (I) ou les sels pharmacologiquement acceptables du composé décrit par celle-ci, où R3 est un alkyle en C1-C9 substitué avec un atome de fluor. Ces composés sont utiles en tant qu'agents antiarythmiques de classe III n'ayant pas l'effet secondaire indésirable qu'est la tachycardie ventriculaire polymorphe et sont stables vis-à-vis d'un métabolisme rapide. L'invention décrit également l'utilisation desdits composés de formule (I) dans des préparations servant au traitement d'arythmies cardiaques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiarrhythmic (s)-enantiomers of methanesulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiarrhythmic (s)-enantiomers of methanesulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic (s)-enantiomers of methanesulfonamides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1677827

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.